Sonothera develops ultrasound-mediated gene delivery platform for genetic disorders

Startup Sonothera is testing a novel delivery mechanism using ultrasound to transport gene therapies into cells, targeting conditions like muscular dystrophy. The efficacy and safety of this platform remain unproven in clinical trials, but the technology represents a potential shift in overcoming current viral vector delivery limitations.